Abstract
We review the cardiovascular effects of newer antidepressants. Although further studies are warranted, the safety of the selective serotonin reuptake inhibitors and the serotonin norepinephrine reuptake inhibitors on patients with comorbid cardiac conditions is impressive. Newer antidepressants should be considered as first-line agents for the treatment of depression in patients with and without cardiovascular disease.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 305-309 |
| Number of pages | 5 |
| Journal | Anadolu Kardiyoloji Dergisi |
| Volume | 7 |
| Issue number | 3 |
| State | Published - Sep 1 2007 |
Keywords
- Antidepressant drugs
- Atrial fibrillation
- Blood pressure
- Bradycardia
- Cardiac death
- Cardiovascular eftects
- Electrocardiogram
- Hypertension
- Hypotension
- QT interval
- Tachycardia
- Ventricular premature beats
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine